Labcorp Holdings INC Form 4 insider transactions

Sandra van der Vaart, EVP and Chief Legal Officer of Laboratory Corporation of America Holdings (Labcorp), reports the vesting of restricted stock units and subsequent stock sales to cover tax obligations.

Brian J. Caveney, EVP, President of ED, CMO & CSO at Laboratory Corporation of America Holdings (Labcorp), reports the vesting of restricted stock units and subsequent tax withholding.

EVP, Pres Diagnostics & COO Mark S. Schroeder reports the vesting of restricted stock units and subsequent stock withholding for tax obligations.

Adam Schechter, President and CEO of Laboratory Corporation of America Holdings, reports the exercise of restricted stock units and subsequent disposal of shares to cover tax obligations.

Jonathan P. DiVincenzo, EVP, Pres, Central Labs & Intl at Laboratory Corp of America Holdings, reports the vesting and subsequent transactions of restricted stock units.

Peter Wilkinson, SVP and Chief Accounting Officer of Laboratory Corporation of America Holdings (Labcorp), reports the vesting and subsequent transaction of Restricted Stock Units (RSUs).

EVP and Chief Marketing Officer of Laboratory Corporation of America Holdings, Amy B. Summy, reports the vesting of restricted stock units and subsequent stock withholding for tax obligations.

Labcorp's CFO, Glenn Eisenberg, reported the vesting of restricted stock units (RSUs) and subsequent stock withholding to cover tax obligations.

Lance Berberian, EVP, CIO & CTO of Laboratory Corporation of America Holdings, reports the vesting and subsequent disposal of shares to cover tax obligations.

Mark S. Schroeder, EVP, Pres Diagnostics & COO of Laboratory Corporation of America Holdings, reports exercising stock options and selling shares on March 7, 2024.

Amy B. Summy, EVP and Chief Marketing Officer of Laboratory Corp of America Holdings, sold 227 shares of common stock on March 7, 2024, at a price of $218.45 per share.